Qiagen NV (QGEN) Posts Q3 EPS of $0.26, Tops by 3c; Raises FY09 EPS
More News related to QGEN
- 2010 IR Global Rankings: Invitation for Investors and Analysts Vote for Companies with the Best IR Program and for the Best IR Officer
- Xenomics, Inc. and Its Subsidiary TrovaGene, Inc. Announce HPV Patent Filing Based on Transrenal DNA Technology
- Qiagen NV (QGEN) Posts Q3 EPS of $0.26, Tops by 3c; Raises FY09 EPS
- QIAGEN Reports Strong Third Quarter 2009 Results
- Trading Radar for 11/10: Tyco Int. (TYC), ArvinMeritor (ARM), Clearwire (CLWR), American Apparel (APP) Report
More News related to Earnings
- DryShips (DRYS) Cancels Acquisition Plans for Two Panamax Vessels
- Arthur J. Gallagher & Co. (AJG) Completes $150M Senior Unsecured Note Private Placement
- Inphi Corporation Files Patent Infringement Suit Against Netlist (NLST)
- Gabelli Discloses 6.9% Stake in Semitool (SMTL), Now 4th Largest Shareholder
- Synovis Life's (SYNO) Veritas Collagen Matrix Published in American Journal of Surgery
Qiagen NV (NASDAQ: QGEN) reports Q3 EPS of $0.26, 3 cents better than the analyst estimate of $0.23. Revenue for the quarter was $259.7 million, which compares to the estimate of $256.9 million.
Raises FY09 EPS from $0.86 - $0.90 to $0.88 - $0.90, versus $0.85 consensus.
Related Categories
EarningsGuidance
Stocks Mentioned
+0.13Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
